In this issue:
Remote pulmonary artery pressure monitoring in chronic HF
CTS associated with subsequent HF
RAS inhibition and outcomes in HFREF and advanced kidney disease
CRP and incident HF risk in patients with CV disease
LBBAP vs. BVP in CRT candidates
Torsemide vs. furosemide in hospitalised HF: symptoms and QOL
Anaemia: effect of sacubitril-valsartan
Neurohormonal antagonist initiation after HF hospitalisation in older adults
Predictors of long-term CV and non-CV mortality in HFPEF
HF pharmacotherapies and outcomes in obese vs. nonobese HFREF patients
Please login below to download this issue (PDF)